
Porton Pharma Solutions Ltd. — Investor Relations & Filings
Porton Pharma Solutions Ltd. is a global contract development and manufacturing organization (CDMO) providing end-to-end solutions for the pharmaceutical and biotechnology sectors. The company specializes in the development and manufacturing of small molecule APIs, intermediates, and drug products, while expanding its capabilities into biologics and cell and gene therapies. Its service portfolio encompasses process research and development, analytical services, pilot-scale production, and large-scale commercial manufacturing. Porton operates a network of R&D centers and manufacturing facilities designed to meet international regulatory standards, including those of the FDA and EMA. By leveraging an integrated technology platform, the company supports clients throughout the entire drug lifecycle, from preclinical development to commercialization, focusing on operational excellence and supply chain security.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事候选人声明(曹国华) | 2025-03-28 | Chinese | |
| 董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告 | 2025-03-28 | Chinese | |
| 2024年年度报告摘要 | 2025-03-28 | Chinese | |
| 公司章程修正案 | 2025-03-28 | Chinese | |
| 董事会对独董独立性评估的专项意见 | 2025-03-28 | Chinese | |
| 关于监事会换届选举的公告 | 2025-03-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36838493 | 独立董事候选人声明(曹国华) | 2025-03-28 | Chinese | ||
| 36838486 | 董事会审计委员会对会计师事务所2024年度履职情况评估及履行监督职责情况的报告 | 2025-03-28 | Chinese | ||
| 36838485 | 2024年年度报告摘要 | 2025-03-28 | Chinese | ||
| 36838482 | 公司章程修正案 | 2025-03-28 | Chinese | ||
| 36838470 | 董事会对独董独立性评估的专项意见 | 2025-03-28 | Chinese | ||
| 36838462 | 关于监事会换届选举的公告 | 2025-03-28 | Chinese | ||
| 36838457 | 2024年环境、社会及治理报告 | 2025-03-28 | Chinese | ||
| 36838115 | 股东会议事规则(2025年3月) | 2025-03-28 | Chinese | ||
| 36838107 | 2024年度关于营业收入扣除情况的专项核查意见 | 2025-03-28 | Chinese | ||
| 36838090 | 董事会议事规则(2025年3月) | 2025-03-28 | Chinese | ||
| 36838077 | 关于2025年度开展以套期保值为目的的外汇衍生品交易业务的公告 | 2025-03-28 | Chinese | ||
| 36838061 | 2024年度董事会工作报告 | 2025-03-28 | Chinese | ||
| 36838054 | 董事会决议公告 | 2025-03-28 | Chinese | ||
| 36838040 | 关于2025年度向银行申请授信额度的公告 | 2025-03-28 | Chinese | ||
| 36838011 | 独立董事提名人声明(二) | 2025-03-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Porton Pharma Solutions Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55356/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55356 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55356 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55356 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55356}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Porton Pharma Solutions Ltd. (id: 55356)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.